News
#India's First Indigenously-developed Receptor Binding Domain Protein Sub-unit ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#India's first indigenously-developed receptor binding domain protein sub-unit #COVID19 vaccine, #Corbevax, developed by Biological E Ltd, has received the Drug Controller General of India's approval for Emergency Use Authorization .'
#India's first indigenously-developed receptor binding domain (RBD) protein sub-unit #COVID19 vaccine, #Corbevax, developed by Biological E Ltd, has received the Drug Controller General of India's approval for Emergency Use Authorization (EUA). pic.twitter.com/KdiD8I228E— IANS Tweets (@ians_india) December 29, 2021
(The above story first appeared on LatestLY on Dec 29, 2021 10:22 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
